Expertise in
2
conditions

Vicky M. Coyle

Belfast, NIR, GB 
Expertise in
2
conditions
Belfast, NIR, GB 

Overview

Vicky Coyle practices practicing medicine in Belfast, United Kingdom.

Ms. Coyle is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Sepsis, Colorectal Cancer, Agranulocytosis, and Transient Erythroblastopenia of Childhood.

She is actively involved in clinical research, co-authoring 23 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Belfast, NIR, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer
A Phase II Trial Assessing Nivolumab in Class II Expressing Microsatellite Stable Colorectal Cancer
Enrollment Status: Completed
Publish Date: April 22, 2026
Intervention Type: Drug
Study Phase: Phase 2
A Phase 1/2 Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination With Gemcitabine Plus Cisplatin or Gemcitabine Alone in Subjects With Advanced Cancer
A Phase 1/2 Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination With Gemcitabine Plus Cisplatin or Gemcitabine Alone in Subjects With Advanced Cancer
Enrollment Status: Completed
Publish Date: June 22, 2023
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase 1/2 Trial of SRA737 (a Chk1 Inhibitor) Administered Orally in Subjects With Advanced Cancer
A Phase 1/2 Trial of SRA737 (a Chk1 Inhibitor) Administered Orally in Subjects With Advanced Cancer
Enrollment Status: Completed
Publish Date: June 18, 2023
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

23 Total Publications

Prevalence and clinical impact of PIK3CA and PTEN alterations from reflex genomic testing of newly diagnosed colorectal cancer: a population-based series.
Prevalence and clinical impact of PIK3CA and PTEN alterations from reflex genomic testing of newly diagnosed colorectal cancer: a population-based series.
Journal: Frontiers in oncology
Published: May 22, 2026

Frequently Asked Questions about Vicky M. Coyle

Is Vicky M. Coyle a top-rated expert for Sepsis?

MediFind is an objective health platform that identifies experts based on real-world data. Vicky M. Coyle is classified as an Advanced expert for Sepsis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Vicky M. Coyle participate in research or clinical trials?

Yes. Vicky M. Coyle has published 23 articles and abstracts on conditions like Sepsis. You can view a list of Vicky M. Coyle's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Coyle's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile